Cargando…

Contribution of Leishmania braziliensis antigen-specific CD4(+) T, CD8(+) T, NK and CD3(+)CD56(+)NKT cells in the immunopathogenesis of cutaneous leishmaniasis patients: Cytotoxic, activation and exhaustion profiles

The pathogenesis of cutaneous leishmaniasis (CL) caused by Leishmania (Viannia) braziliensis is dictated mainly by the immune-mediated-tissue inflammation developed. The understanding of the immunological mechanisms that generate tissue damage or resolution of lesions is the key to the development o...

Descripción completa

Detalles Bibliográficos
Autores principales:	Cunha, Clarissa F., Ferraz-Nogueira, Raquel, Costa, Vanessa F. A., Pimentel, Maria Inês F., Chometon, Thaize Q., Lyra, Marcelo R., Schubach, Armando O., Da-Cruz, Alda Maria, Bertho, Alvaro Luiz
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2020
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7089553/ https://www.ncbi.nlm.nih.gov/pubmed/32203546 http://dx.doi.org/10.1371/journal.pone.0229400

Ejemplares similares

CD3(+)CD4(neg)CD8(neg) (double negative) T lymphocytes and NKT cells as the main cytotoxic-related-CD107a(+) cells in lesions of cutaneous leishmaniasis caused by Leishmania (Viannia) braziliensis
por: Ferraz, Raquel, et al.
Publicado: (2017)

Apoptosis and frequency of total and effector CD8(+) T lymphocytes from cutaneous leishmaniasis patients during antimonial therapy
por: Ferraz, Raquel, et al.
Publicado: (2015)

T-cell receptor Vβ repertoire of CD8(+) T-lymphocyte subpopulations in cutaneous leishmaniasis patients from the state of Rio de Janeiro, Brazil
por: Ferraz, Raquel, et al.
Publicado: (2015)

The Function of CD3(+)CD56(+) NKT-Like Cells in HIV-Infected Individuals
por: Jiang, Yongjun, et al.
Publicado: (2014)

Can we define CD3(+)CD56(+) cells as NKT cells with impunity?
por: Lenart, Marzena, et al.
Publicado: (2021)

PD-1 blockade improves the anti-tumor potency of exhausted CD3(+)CD56(+) NKT-like cells in patients with primary hepatocellular carcinoma
por: Tao, Longxiang, et al.
Publicado: (2021)

Dysfunction of circulating CD3(+)CD56(+) NKT-like cells in type 2 diabetes mellitus
por: Tang, Ling, et al.
Publicado: (2023)

The frequencies of peripheral blood CD5(+)CD19(+) B cells, CD3(−)CD16(+)CD56(+) NK, and CD3(+)CD56(+) NKT cells and serum interleukin-10 in patients with multiple sclerosis and neuromyelitis optica spectrum disorder
por: Khani, Leila, et al.
Publicado: (2022)

Altered phenotypic and functional characteristics of CD3(+)CD56(+) NKT-like cells in human gastric cancer
por: Peng, Liu-sheng, et al.
Publicado: (2016)

Baseline CD3+CD56+ (NKT-like) Cells and the Outcome of Influenza Vaccination in Children Undergoing Chemotherapy
por: Leibinger, Evelin A., et al.
Publicado: (2021)

NKT-Like (CD3+CD56+) Cells in Chronic Myeloid Leukemia Patients Treated With Tyrosine Kinase Inhibitors
por: Almeida, Jani-Sofia, et al.
Publicado: (2019)

NK cells CD56(bright) and CD56(dim) subset cytokine loss and exhaustion is associated with impaired survival in myeloma
por: Seymour, Frances, et al.
Publicado: (2022)

Trained Immunity of IL-12-, IL-15-, and IL-18-Induced CD(3)+CD(56)+ NKT-Like Cells
por: Zhu, Siyu, et al.
Publicado: (2022)

Alterations in the CD56(−) and CD56(+) T Cell Subsets during COVID-19
por: Vavilova, Julia D., et al.
Publicado: (2023)

Central and Effector Memory Human CD4(+) and CD8(+) T Cells during Cutaneous Leishmaniasis and after In Vitro Stimulation with Leishmania (Viannia) braziliensis Epitopes
por: de Oliveira, Beatriz Coutinho, et al.
Publicado: (2023)

CD3(+)/CD56(+) NKT-like Cells Show Imbalanced Control Immediately after Exercise in Delayed-Onset Muscle Soreness
por: Sonkodi, Balázs, et al.
Publicado: (2022)

Immunogenicity of Potential CD4(+) and CD8(+) T Cell Epitopes Derived From the Proteome of Leishmania braziliensis
por: e Silva, Rafael de Freitas, et al.
Publicado: (2020)

What is CD4+CD56+ malignancy and how should it be treated?
por: Reimer, P, et al.
Publicado: (2003)

Diagnostic Challenges of CD4(+)/CD56(+)/CD123(+) hematological neoplasms
por: Thiago, Leandro S., et al.
Publicado: (2013)

NKT-like (CD3 + CD56+) cells differ from T cells in expression level of cellular protective proteins and sensitivity to stimulation in the process of ageing
por: Kaszubowska, Lucyna, et al.
Publicado: (2022)

Altered phenotypic and metabolic characteristics of FOXP3(+)CD3(+)CD56(+) natural killer T (NKT)-like cells in human malignant pleural effusion
por: Wang, Zi-Hao, et al.
Publicado: (2022)

Combination of In Silico Methods in the Search for Potential CD4(+) and CD8(+) T Cell Epitopes in the Proteome of Leishmania braziliensis
por: e Silva, Rafael de Freitas, et al.
Publicado: (2016)

CD3, CD4, CD8, CD19 and CD16/CD56 positive cells in tuberculosis infection and disease: Peculiar features in children
por: Venturini, Elisabetta, et al.
Publicado: (2019)

Local CD4+, CD8+ and CD56+ T-lymphocite Reaction on Primary Lung Cancer
por: Jusufovic, Edin, et al.
Publicado: (2011)

CD56(dim)CD16(high) and CD56(bright)CD16(−) cell percentages associated with maximum knee extensor strength and incidence of death in elderly
por: Senpuku, Hidenobu, et al.
Publicado: (2016)

Pollution of mycological surfaces in hospital emergency departments correlates positively with blood NKT CD3(+) 16(+) 56(+) and negatively with CD4(+) cell levels of their staff
por: Suska, Milena, et al.
Publicado: (2016)

Distinct Signatures in the Receptor Repertoire Discriminate CD56bright and CD56dim Natural Killer Cells
por: Schwane, Vera, et al.
Publicado: (2020)

CD3+, CD56+, CD4−, CD8−, CD20−, CD30− Peripheral T-Cell Non-Hodgkin's Lymphoma: A Rare Case Report
por: Jagati, Ashish, et al.
Publicado: (2017)

The phenotype of CD3–CD56(bright) and CD3–CD56(dim) natural killer cells in systemic lupus erythematosus patients and its relation to disease activity
por: Soelistyoningsih, Dwi, et al.
Publicado: (2022)

The diagnostic power of CD117, CD13, CD56, CD64, and MPO in rapid screening acute promyelocytic leukemia
por: Tran, Vinh Thanh, et al.
Publicado: (2020)

Development of an immunogen containing CD4(+)/CD8(+) T-cell epitopes for the prophylaxis of tegumentary leishmaniasis
por: de Andrade Ferraz, Isabela, et al.
Publicado: (2022)

Multiples aberrant phenotypes in multiple myeloma patient expressing CD56(-), CD28(+),CD19(+)
por: Leite, Luiz Arthur Calheiros, et al.
Publicado: (2012)

Identification of Cytolytic CD161(−)CD56(+) Regulatory CD8 T Cells in Human Peripheral Blood
por: Hu, Dan, et al.
Publicado: (2013)

Activation of Blood CD3(+)CD56(+)CD8(+) T Cells during Pregnancy and Multiple Sclerosis
por: de Andrés, Clara, et al.
Publicado: (2017)

CD39 Expression Identifies Terminally Exhausted CD8(+) T Cells
por: Gupta, Prakash K., et al.
Publicado: (2015)

Human Natural Killer Cell Maturation Defect Supports In Vivo CD56(bright) to CD56(dim) Lineage Development
por: Domaica, Carolina Inés, et al.
Publicado: (2012)

To be or not to be: the role of CD56 in multiple myeloma
por: Cottini, Francesca, et al.
Publicado: (2023)

Quantitative serum determination of CD3, CD4, CD8, CD16, and CD56 in women with primary infertility: The role of cell-mediated immunity
por: Shakerian, Behzad, et al.
Publicado: (2022)

Analysis of CD4, CD8, CD19, CD56-16, CD64, QuantiFERON biomarkers in exudative lymphocyte-dominant pleural effusion
por: Mehraban, Zahra, et al.
Publicado: (2022)

CD4+CD56+CD68+hematopoietic tumor of probable plasmacytoid monocyte derivation with weak expression of cytoplasmic CD3.
por: Ko, Young Hyeh, et al.
Publicado: (2002)

Cannot write session to /tmp/vufind_sessions/sess_r2qflh9igagrapbgebcv8th205